Trial Profile
Effect of sofosbuvir regimens in patients with Hepatitis C Genotype 3
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 06 Aug 2015 New trial record